Comparison 3. ARBs versus ACEis.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Residual kidney function [mL/min/1.73 m²]	2		Mean Difference (IV, Random, 95% CI)	Totals not selected
1.1 1 month	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
1.2 12 months	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
2 Cardiovascular events (nonfatal)	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
3 Anuria	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
4 Systolic BP	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
5 Diastolic BP	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
6 Peritonitis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
7 Cough	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
8 Serum potassium	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
9 Hyperkalaemia	2	144	Risk Ratio (M‐H, Random, 95% CI)	1.2 [0.40, 3.63]